1.57BMarket Cap
LossP/E TTM
Forte Biosciences Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Forte Biosciences Inc is 7.89, ranking 137 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -16.72, which is -98.47% below the recent high of -0.26 and -2519.84% above the recent low of -438.05.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.